Search clinical trials for: Peroxisomal Disorders

Total 145261 results

Danish Headache Center
EUROHEAD

Completed

Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2

Healthy Volunteers | Familial Hemiplegic Migraine Type 1 and 2

Denmark
University of British Columbia

Completed

REMStar Auto With C-Flex - In-Laboratory Performance v. Conventionally Titrated CPAP Therapy: Performances and Preferences

Obstructive Sleep Apnoea Hypopnoea Syndrome

Canada
Icahn School of Medicine at Mount Sinai

Unknown

Guanfacine to Treat Borderline Personality Disorder

Borderline Personality Disorder

United States
Eli Lilly and Company

Completed

Local Registration Trial in China Humalog Mix 50

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
AstraZeneca

Completed

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

Type 2 Diabetes

United States, Canada, France, Mexico
Nemours Children's Clinic
Washington University School of Medicine

Completed

Behavior Therapy for Families of Diabetic Adolescents

Type 1 Diabetes Mellitus

United States
Agency for Healthcare Research and Quality (AHRQ)

Completed

Care Management for Patients With Alzheimer Disease and Their Family Caregivers

Dementia | Alzheimer's Disease

United States
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
National Center for Complementary and Integrative...

Completed

Valerian to Improve Sleep in Patients With Parkinson's Disease

Parkinson's Disease | Insomnia

United States
University Hospital Freiburg
Almased Wellness GmbH

Completed

Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.

Obesity | Metabolic Syndrome

Germany
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
National Center for Complementary and Integrative...

Completed

High Intensity Light Therapy in Alzheimer's Disease

Dementia | Alzheimer's Disease

United States
Tawam Hospital

Unknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Pfizer

Completed

Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

Impotence

United States
Pfizer

Completed

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

Impotence
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Tripler Army Medical Center

Unknown

Comparison of Body and Room Temperature Saline in Urodynamics

Urinary Incontinence

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Hoersholm Hospital
GlaxoSmithKline

Completed

Epidemiology Study in Major Orthopaedic Surgery

Quality of Life | Postoperative Complications | Thrombosis

Denmark
Drug Commission of the German Medical Association
Madaus AG

Terminated

Cholesterol-Lowering Effects of Policosanol

Hypercholesterolemia | Combined Hyperlipidemia
Eli Lilly and Company

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

Alzheimer's Disease

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Schizophrenia

United States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Completed

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

Acute Lung Injury | Respiratory Distress Syndrome, Adult

United States, Belgium, Spain, Canada, Australia, New Zealand
Eli Lilly and Company

Completed

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Schizophrenia | Schizoaffective Disorder

Australia, Belgium, Brazil, Croatia, Czech Republic, Mexico, Slovakia, Spain
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

Anemia | Thrombocytopenia | Neutropenia | Leukemia, T-Cell | Lymphocytosis

United States
Pfizer

Completed

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Anxiety Neuroses

Spain, Belgium, South Africa, Germany, United Kingdom, Poland, Austria, Estonia, France, Israel, Italy, Latvia, Netherlands, Ukraine
The University of Hong Kong

Completed

Randomized Controlled Trial of Acupuncture Versus Sham Acupuncture in Autistic Spectrum Disorder

Autistic Disorder | Autism

Hong Kong
Advanced-J
Japan Heart Foundation

Unknown

A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Japan
Abbott Molecular

Unknown

Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples

Genetic Disorders
National Institute of Neurological Disorders and...

Completed

Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)

Muscle Rigidity | Spasm | Stiff Man Syndrome

United States
Stanford University

Completed

Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults

Obesity | Metabolic Syndrome | Impaired Glucose Tolerance

United States
The University of Hong Kong

Completed

Use of Acupuncture In Children With Autistic Spectrum Disorder

Autistic Disorder | Autism

Hong Kong
National Institute of Mental Health (NIMH)

Completed

Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders

Bipolar Disorder | Unipolar Depression | Mood Disorder

United States
Demostudiet

Unknown

Trial Investigating the Effect of Different Exercise Forms on Depression

Depression

Denmark

Search clinical trials for: Peroxisomal Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations